Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of Confo Therapeutics is 0.3% (very low). The company has been active since 2015 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
Based on State Gazette and CBE data.
Financials
No processed annual-account figures available.
To financials
People & board
29 mandates
23
active directors
VANGINDERTAEL JeroenDirectorCVBioConsulting BVManaging directorDieter WeinandDirector+26 in history
All directors & mandates Publicationslatest 04-03-2026
100
publications in the State GazetteChange in the board of directorsAll publications & acts Network & structure
55
connected companiesSee network & structure
Connections
55 connected companiesParent · 455 subsidiaries · 9 locations
Control→
Parent · 474 subsidiaries · 5 locations
Control→
Parent · 45 subsidiaries · 1 location
Control→
Parent · 1 subsidiary · 1 location
Control→
Parent · 1 subsidiary · 1 location
Control→
Trust signals
3 signalsEstablished
Founded in 2015 — 11 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags
0 events
No administrative flags
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone0.3%
Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector
−Lower-risk legal form
−
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Company registry (CBE)
Crossroads BankActivities
Speur- en ontwikkelingswerk op biotechnologisch gebied72101Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied72109Speur- en ontwikkelingswerk op biotechnologisch gebied72110Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied72190
Primary activity highlighted.
Names & trade names
| Legal nameNL | Confo Therapeutics |
| AbbreviationNL | Confo |
Registered office
Technologiepark-Zwijnaarde 30
9052 Gent, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.